Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice
Open Access
- 1 December 2011
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 121 (12), 4921-4930
- https://doi.org/10.1172/jci59777
Abstract
The morbidity and mortality associated with respiratory virus infection is felt most keenly among the elderly. T cells are necessary for viral clearance, and many age-dependent intrinsic T cell defects have been documented. However, the development of robust T cell responses in the lung also requires respiratory DCs (rDCs), which must process antigen and migrate to draining LNs (DLNs), and little is known about age-related defects in these T cell–extrinsic functions. Here, we show that increases in prostaglandin D2 (PGD2) expression in mouse lungs upon aging correlate with a progressive impairment in rDC migration to DLNs. Decreased rDC migration resulted in diminished T cell responses and more severe clinical disease in older mice infected with respiratory viruses. Diminished rDC migration associated with virus-specific defects in T cell responses and was not a result of cell-intrinsic defect, rather it reflected the observed age-dependent increases in PGD2 expression. Blocking PGD2 function with small-molecule antagonists enhanced rDC migration, T cell responses, and survival. This effect correlated with upregulation on rDCs of CCR7, a chemokine receptor involved in DC chemotaxis. Our results suggest that inhibiting PGD2 function may be a useful approach to enhance T cell responses against respiratory viruses in older humans.This publication has 60 references indexed in Scilit:
- Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseasesNature Reviews Drug Discovery, 2007
- Diverse and Potent Chemokine Production by Lung CD11bhigh Dendritic Cells in Homeostasis and in Allergic Lung InflammationThe Journal of Immunology, 2007
- Discovery of a Potent and Selective Prostaglandin D2 Receptor Antagonist, [(3R)-4-(4-Chloro- benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic Acid (MK-0524)Journal of Medicinal Chemistry, 2007
- Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte functionJournal of Leukocyte Biology, 2006
- All Roads Lead to RomeImmunity, 2004
- The lung as a privileged site for the beneficial actions of PGE2Trends in Immunology, 2004
- Prostaglandin D2 Inhibits Airway Dendritic Cell Migration and Function in Steady State Conditions by Selective Activation of the D Prostanoid Receptor 1The Journal of Immunology, 2003
- Pivotal roles of the parasite PGD2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasionEuropean Journal of Immunology, 2003
- Differential Antigen Presentation Regulates the Changing Patterns of CD8+ T Cell Immunodominance in Primary and Secondary Influenza Virus InfectionsThe Journal of Experimental Medicine, 2003
- Cutting Edge: Rapid In Vivo Killing by Memory CD8 T CellsThe Journal of Immunology, 2003